Patent EP0232744A2 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0232744A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

Inhibitors of the reverse transcriptase for prophylaxis and therapy of retrovirus infections in mammals

Assignee: DIRINGER, HEINO, PROF. DR.
•
Filing: 1987-01-15
•
Granted: —
•
Expires: 2007-01-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Inhibitors of the Reverse Transcriptase for Prophylaxis and Therapy of Retrovirus Infections im Mammals. The subject matter of the invention is the use of organic polymers which contain inorganic anionic groups for prophylaxis and therapy of retrovirus infections in mammals.

Inventors

  • 👤 Heino Dr. Diringer
  • 👤 Karin Dr. Mölling

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-10 01:21
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/715; C; C12; C12N; C12N9/00; C12N9/10; C12N9/12; C12N9/1241; C12N9/1276; A61K31/737; A61K31/74; A61K31/795; A61P; A61P31/00; A61P31/12; C08; C08B; C08B37/00; C08B37/0006; C08B37/0009; C08B37/0021; C12N9/99; C12Y; C12Y207/00; C12Y207/07; C12Y207/07049

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 26 words
The use of organic polymeric compounds containing inorganic anionic groups for the preparation of a medicament for prophylaxis and therapeutic treatment of retrovirus infections of mammals.
Claim 2
Dependent Claim 26 words
The use of organic polymeric compounds containing inorganic anionic groups for the preparation of a medicament for prophylaxis and therapeutic treatment of retrovirus infections of mammals.
Claim 3
Dependent Claim 25 words
Embodiment according to Claim 1, wherein the organic polymeric compound is a carbohydrate which does not contain carboxyl (-COOH) and amino (-NH 2 ) groups.
Claim 4
Dependent Claim 14 words
Embodiment according to Claim 2, wherein the polymeric carbohydrate is composed of monomeric pentoses.
Claim 5
Dependent Claim 14 words
Embodiment according to Claim 2, wherein the polymeric carbohydrate is composed of monomeric hexoses.
Claim 6
Dependent Claim 22 words
Embodiment according to Claim 3 or 4, wherein the polymeric carbohydrate is composed of pyranose units having 5 or 6 carbon atoms.
Claim 7
Dependent Claim 12 words
Embodiment according to Claim 5, wherein the pyranose units are xylopyranose groups.
Claim 8
Dependent Claim 12 words
Embodiment according to Claim 5, wherein the pyranose units are glucopyranose groups.
Claim 9
Dependent Claim 16 words
Embodiment according to Claim 3, 5 and 6, wherein the polymeric carbohydrate is a pentosane polysulfate.
Claim 10
Dependent Claim 14 words
Embodiment according to Claim 8, wherein the polymeric carbohydrate is pentosane polysulfate MW 5,000.
Claim 11
Dependent Claim 24 words
Embodiment according to Claim 4, 5 and 7, wherein the polymeric carbohydrate is a dextran sulfate with a molecular weight of at least 6,000.
Claim 12
Dependent Claim 14 words
Embodiment according to Claim 10, wherein the polymeric carbohydrate is dextran sulfate MW 8,000.
Claim 13
Dependent Claim 14 words
Embodiment according to Claim 10, wherein the polymeric carbohydrate is dextran sulfate MW 500,000.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag